Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Association of circulating inflammation proteins and gallstone disease.

Liu Z, Kemp TJ, Gao YT, Corbel A, McGee EE, Wang B, Shen MC, Rashid A, Hsing AW, Hildesheim A, Pfeiffer RM, Pinto LA, Koshiol J.

J Gastroenterol Hepatol. 2018 Apr 19. doi: 10.1111/jgh.14265. [Epub ahead of print]

PMID:
29671891
2.

Oganesson: a most unusual 'inert gas'.

Macrae RM, Kemp TJ.

Sci Prog. 2018 Jun 1;101(2):101-120. doi: 10.3184/003685018X15173976099750. Epub 2018 Apr 18. No abstract available.

PMID:
29669628
3.

Evaluation of HPV-16 and HPV-18 specific antibody measurements in saliva collected in oral rinses and merocel® sponges.

Parker KH, Kemp TJ, Pan Y, Yang Z, Giuliano AR, Pinto LA.

Vaccine. 2018 May 3;36(19):2705-2711. doi: 10.1016/j.vaccine.2018.03.034. Epub 2018 Apr 6.

PMID:
29631883
4.

Circulating Levels of Inflammatory Proteins and Survival in Patients with Gallbladder Cancer.

Liu Z, Kemp TJ, Gao YT, Corbel A, McGee EE, Roa JC, Wang B, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA, Koshiol J.

Sci Rep. 2018 Apr 4;8(1):5671. doi: 10.1038/s41598-018-23848-8.

5.

Circulating inflammatory proteins and gallbladder cancer: Potential for risk stratification to improve prioritization for cholecystectomy in high-risk regions.

Koshiol J, Gao YT, Corbel A, Kemp TJ, Shen MC, Hildesheim A, Hsing AW, Rashid A, Wang B, Pfeiffer RM, Pinto LA.

Cancer Epidemiol. 2018 Jun;54:25-30. doi: 10.1016/j.canep.2018.03.004. Epub 2018 Mar 16.

PMID:
29554539
6.

An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study.

Beachler DC, Pinto LA, Kemp TJ, Nyitray AG, Hildesheim A, Viscidi R, Schussler J, Kreimer AR, Giuliano AR.

Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):496-502. doi: 10.1158/1055-9965.EPI-17-0853. Epub 2018 Feb 23.

PMID:
29475967
7.

Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.

Kreimer AR, Herrero R, Sampson JN, Porras C, Lowy DR, Schiller JT, Schiffman M, Rodriguez AC, Chanock S, Jimenez S, Schussler J, Gail MH, Safaeian M, Kemp TJ, Cortes B, Pinto LA, Hildesheim A, Gonzalez P; Costa Rica HPV Vaccine Trial (CVT) Group.

Vaccine. 2018 Jan 20. pii: S0264-410X(18)30018-5. doi: 10.1016/j.vaccine.2017.12.078. [Epub ahead of print]

8.

Industrial hog farming is associated with altered circulating immunological markers.

Hofmann JN, Shiels MS, Friesen MC, Kemp TJ, Chaturvedi AK, Lynch CF, Parks CG, Pinto LA, Hildesheim A, Alavanja MCR, Beane Freeman LE.

Occup Environ Med. 2018 Mar;75(3):212-217. doi: 10.1136/oemed-2017-104519. Epub 2017 Oct 21.

PMID:
29055885
9.

A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai.

Shiels MS, Shu XO, Chaturvedi AK, Gao YT, Xiang YB, Cai Q, Hu W, Shelton G, Ji BT, Pinto LA, Kemp TJ, Rothman N, Zheng W, Hildesheim A, Lan Q.

Carcinogenesis. 2017 Oct 1;38(10):1004-1010. doi: 10.1093/carcin/bgx075.

PMID:
28981818
10.

Occupational exposure to diesel engine exhaust and alterations in immune/inflammatory markers: a cross-sectional molecular epidemiology study in China.

Bassig BA, Dai Y, Vermeulen R, Ren D, Hu W, Duan H, Niu Y, Xu J, Shiels MS, Kemp TJ, Pinto LA, Fu W, Meliefste K, Zhou B, Yang J, Ye M, Jia X, Meng T, Wong JYY, Bin P, Hosgood HD 3rd, Hildesheim A, Silverman DT, Rothman N, Zheng Y, Lan Q.

Carcinogenesis. 2017 Oct 26;38(11):1104-1111. doi: 10.1093/carcin/bgx081.

PMID:
28968774
11.

Durability of Protection Afforded by Fewer Doses of the HPV16/18 Vaccine: The CVT Trial.

Safaeian M, Sampson JN, Pan Y, Porras C, Kemp TJ, Herrero R, Quint W, van Doorn LJ, Schussler J, Lowy DR, Schiller J, Schiffman MT, Rodriguez AC, Gail MH, Hildesheim A, Gonzalez P, Pinto LA, Kreimer AR; Costa Rica HPV Vaccine Trial (CVT) Group.

J Natl Cancer Inst. 2018 Feb 1;110(2). doi: 10.1093/jnci/djx158.

PMID:
28954299
12.

A brief 100 year history of carbon.

Kemp TJ.

Sci Prog. 2017 Sep 1;100(3):293-298. doi: 10.3184/003685017X14994318577435. Epub 2017 Aug 5.

PMID:
28779761
13.

Associations between self-reported diabetes and 78 circulating markers of inflammation, immunity, and metabolism among adults in the United States.

Van Dyke AL, Lang Kuhs KA, Shiels MS, Koshiol J, Trabert B, Loftfield E, Purdue MP, Wentzensen N, Pfeiffer RM, Katki HA, Hildesheim A, Kemp TJ, Pinto LA, Chaturvedi AK, Safaeian M.

PLoS One. 2017 Jul 28;12(7):e0182359. doi: 10.1371/journal.pone.0182359. eCollection 2017.

14.

Femtosecond studies: observing transition states and other ultra-short-lived species.

Kemp TJ.

Sci Prog. 2016 Jun 1;99(2):133-152. doi: 10.3184/003685016X14616057013539.

PMID:
28742470
15.

100 years of X-ray crystallography.

Kemp TJ, Alcock NW.

Sci Prog. 2017 Mar 1;100(1):25-44. doi: 10.3184/003685017X14858694684395.

PMID:
28693671
16.

Impact of freeze-thaw cycles on circulating inflammation marker measurements.

Huang WY, Kemp TJ, Pfeiffer RM, Pinto LA, Hildesheim A, Purdue MP.

Cytokine. 2017 Jul;95:113-117. doi: 10.1016/j.cyto.2017.02.016. Epub 2017 Mar 3.

PMID:
28260648
17.

Lipopolysaccharide-pathway proteins are associated with gallbladder cancer among adults in Shanghai, China with mediation by systemic inflammation.

Van Dyke AL, Kemp TJ, Corbel AF, Zhu B, Gao YT, Wang BS, Rashid A, Shen MC, Hildesheim A, Hsing AW, Pinto LA, Koshiol J.

Ann Epidemiol. 2016 Oct;26(10):704-709. doi: 10.1016/j.annepidem.2016.08.009. Epub 2016 Aug 31.

18.

Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.

Trabert B, Eldridge RC, Pfeiffer RM, Shiels MS, Kemp TJ, Guillemette C, Hartge P, Sherman ME, Brinton LA, Black A, Chaturvedi AK, Hildesheim A, Berndt SI, Safaeian M, Pinto L, Wentzensen N.

Int J Cancer. 2017 Feb 1;140(3):600-610. doi: 10.1002/ijc.30478. Epub 2016 Nov 7.

19.

Quadrivalent Human Papillomavirus (HPV) Vaccine Induces HPV-Specific Antibodies in the Oral Cavity: Results From the Mid-Adult Male Vaccine Trial.

Pinto LA, Kemp TJ, Torres BN, Isaacs-Soriano K, Ingles D, Abrahamsen M, Pan Y, Lazcano-Ponce E, Salmeron J, Giuliano AR.

J Infect Dis. 2016 Oct 15;214(8):1276-83. doi: 10.1093/infdis/jiw359. Epub 2016 Aug 10.

20.

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.

Faridi RM, Kemp TJ, Dharmani-Khan P, Lewis V, Tripathi G, Rajalingam R, Daly A, Berka N, Storek J, Masood Khan F.

PLoS One. 2016 Jun 24;11(6):e0158242. doi: 10.1371/journal.pone.0158242. eCollection 2016.

21.

Association of inflammatory and other immune markers with gallbladder cancer: Results from two independent case-control studies.

Koshiol J, Castro F, Kemp TJ, Gao YT, Roa JC, Wang B, Nogueira L, Araya JC, Shen MC, Rashid A, Hsing AW, Hildesheim A, Ferreccio C, Pfeiffer RM, Pinto LA.

Cytokine. 2016 Jul;83:217-225. doi: 10.1016/j.cyto.2016.05.003. Epub 2016 May 9.

22.

Circulating CXCR5⁺CD4⁺ T Follicular-Like Helper Cell and Memory B Cell Responses to Human Papillomavirus Vaccines.

Matsui K, Adelsberger JW, Kemp TJ, Baseler MW, Ledgerwood JE, Pinto LA.

PLoS One. 2015 Sep 2;10(9):e0137195. doi: 10.1371/journal.pone.0137195. eCollection 2015.

23.

Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.

Shiels MS, Katki HA, Hildesheim A, Pfeiffer RM, Engels EA, Williams M, Kemp TJ, Caporaso NE, Pinto LA, Chaturvedi AK.

J Natl Cancer Inst. 2015 Jul 28;107(10). pii: djv199. doi: 10.1093/jnci/djv199. Print 2015 Oct.

24.

Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts.

Bassig BA, Shu XO, Koh WP, Gao YT, Purdue MP, Butler LM, Adams-Haduch J, Xiang YB, Kemp TJ, Wang R, Pinto LA, Zheng T, Ji BT, Hosgood HD, Hu W, Yang G, Zhang H, Chow WH, Kim C, Seow WJ, Zheng W, Yuan JM, Lan Q, Rothman N.

Int J Cancer. 2015 Dec 1;137(11):2688-95. doi: 10.1002/ijc.29637. Epub 2015 Jun 26.

25.

Associations of Coffee Drinking with Systemic Immune and Inflammatory Markers.

Loftfield E, Shiels MS, Graubard BI, Katki HA, Chaturvedi AK, Trabert B, Pinto LA, Kemp TJ, Shebl FM, Mayne ST, Wentzensen N, Purdue MP, Hildesheim A, Sinha R, Freedman ND.

Cancer Epidemiol Biomarkers Prev. 2015 Jul;24(7):1052-60. doi: 10.1158/1055-9965.EPI-15-0038-T. Epub 2015 May 21.

26.

Immune status of patients with inherited bone marrow failure syndromes.

Giri N, Alter BP, Penrose K, Falk RT, Pan Y, Savage SA, Williams M, Kemp TJ, Pinto LA.

Am J Hematol. 2015 Aug;90(8):702-8. doi: 10.1002/ajh.24046. Epub 2015 May 28.

27.

Circulating TGF-β1 and VEGF and risk of cancer among liver transplant recipients.

Engels EA, Jennings L, Kemp TJ, Chaturvedi AK, Pinto LA, Pfeiffer RM, Trotter JF, Acker M, Onaca N, Klintmalm GB.

Cancer Med. 2015 Aug;4(8):1252-7. doi: 10.1002/cam4.455. Epub 2015 Apr 27.

28.

Circulating immune/inflammation markers in Chinese workers occupationally exposed to formaldehyde.

Seow WJ, Zhang L, Vermeulen R, Tang X, Hu W, Bassig BA, Ji Z, Shiels MS, Kemp TJ, Shen M, Qiu C, Reiss B, Beane Freeman LE, Blair A, Kim C, Guo W, Wen C, Li L, Pinto LA, Huang H, Smith MT, Hildesheim A, Rothman N, Lan Q.

Carcinogenesis. 2015 Aug;36(8):852-7. doi: 10.1093/carcin/bgv055. Epub 2015 Apr 23.

29.

Application of multiplex arrays for cytokine and chemokine profiling of bile.

Kemp TJ, Castro FA, Gao YT, Hildesheim A, Nogueira L, Wang BS, Sun L, Shelton G, Pfeiffer RM, Hsing AW, Pinto LA, Koshiol J.

Cytokine. 2015 May;73(1):84-90. doi: 10.1016/j.cyto.2015.01.033. Epub 2015 Mar 2.

30.

Association between Regular Aspirin Use and Circulating Markers of Inflammation: A Study within the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Lang Kuhs KA, Hildesheim A, Trabert B, Kemp TJ, Purdue MP, Wentzensen N, Katki HA, Pinto LA, Loftfield E, Safaeian M, Chaturvedi AK, Shiels MS.

Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):825-32. doi: 10.1158/1055-9965.EPI-14-1363. Epub 2015 Feb 23.

31.

A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.

Kemp TJ, Matsui K, Shelton G, Safaeian M, Pinto LA.

Hum Vaccin Immunother. 2015;11(2):337-46. doi: 10.4161/21645515.2014.990851.

32.

Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma.

Purdue MP, Lan Q, Kemp TJ, Hildesheim A, Weinstein SJ, Hofmann JN, Virtamo J, Albanes D, Pinto LA, Rothman N.

Leukemia. 2015 Jun;29(6):1429-31. doi: 10.1038/leu.2015.2. Epub 2014 Jan 8. No abstract available.

33.

Carbon dioxide as a polymer feedstock.

Kemp TJ.

Sci Prog. 2014;97(Pt 3):249-60.

PMID:
25549409
34.

Comparison of adaptive and innate immune responses induced by licensed vaccines for Human Papillomavirus.

Herrin DM, Coates EE, Costner PJ, Kemp TJ, Nason MC, Saharia KK, Pan Y, Sarwar UN, Holman L, Yamshchikov G, Koup RA, Pang YY, Seder RA, Schiller JT, Graham BS, Pinto LA, Ledgerwood JE.

Hum Vaccin Immunother. 2014;10(12):3446-54. doi: 10.4161/hv.34408.

35.

Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay.

Robbins HA, Waterboer T, Porras C, Kemp TJ, Pawlita M, Rodriguez AC, Wacholder S, Gonzalez P, Schiller JT, Lowy DR, Esser M, Matys K, Poncelet S, Herrero R, Hildesheim A, Pinto LA, Safaeian M.

Hum Vaccin Immunother. 2014;10(10):2965-74. doi: 10.4161/21645515.2014.972811.

36.

Cigarette smoking and variations in systemic immune and inflammation markers.

Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, Kitahara CM, Furr M, Li Y, Kemp TJ, Goedert JJ, Chang CM, Engels EA, Caporaso NE, Pinto LA, Hildesheim A, Chaturvedi AK.

J Natl Cancer Inst. 2014 Oct 1;106(11). pii: dju294. doi: 10.1093/jnci/dju294. Print 2014 Nov.

37.

Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance.

Kitahara CM, Trabert B, Katki HA, Chaturvedi AK, Kemp TJ, Pinto LA, Moore SC, Purdue MP, Wentzensen N, Hildesheim A, Shiels MS.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2840-9. doi: 10.1158/1055-9965.EPI-14-0699-T. Epub 2014 Sep 23.

38.

Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in Uganda.

LaMontagne DS, Mugisha E, Pan Y, Kumakech E, Ssemaganda A, Kemp TJ, Cover J, Pinto LA, Safaeian M.

Vaccine. 2014 Oct 29;32(47):6303-11. doi: 10.1016/j.vaccine.2014.08.071. Epub 2014 Sep 16.

PMID:
25218297
39.

A multiplex panel of plasma markers of immunity and inflammation in classical kaposi sarcoma.

Aka PV, Kemp TJ, Rabkin CS, Shiels MS, Polizzotto MN, Lauria C, Vitale F, Pinto LA, Goedert JJ.

J Infect Dis. 2015 Jan 15;211(2):226-9. doi: 10.1093/infdis/jiu410. Epub 2014 Aug 22.

40.

Sensory Nerve Dysfunction and Hallux Valgus Correction: A Prospective Study.

Jastifer JR, Coughlin MJ, Doty JF, Stevens FR, Hirose C, Kemp TJ.

Foot Ankle Int. 2014 Aug;35(8):757-763. Epub 2014 May 7.

PMID:
24807984
41.

Osteochondral Lesions in Surgically Treated Hallux Valgus.

Jastifer JR, Coughlin MJ, Doty JF, Stevens FR, Hirose C, Kemp TJ.

Foot Ankle Int. 2014 Jul;35(7):643-9. doi: 10.1177/1071100714531234. Epub 2014 Apr 7.

PMID:
24709744
42.

Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus.

Robbins HA, Li Y, Porras C, Pawlita M, Ghosh A, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Gonzalez P, Schiller J, Lowy D, Esser M, Matys K, Quint W, van Doorn LJ, Herrero R, Pinto LA, Hildesheim A, Waterboer T, Safaeian M.

BMC Infect Dis. 2014 Mar 3;14:120. doi: 10.1186/1471-2334-14-120.

43.

Comparison of antibody responses to human papillomavirus vaccination as measured by three assays.

Robbins HA, Kemp TJ, Porras C, Rodriguez AC, Schiffman M, Wacholder S, Gonzalez P, Schiller J, Lowy D, Poncelet S, Esser M, Matys K, Hildesheim A, Pinto LA, Herrero R, Safaeian M.

Front Oncol. 2014 Jan 13;3:328. doi: 10.3389/fonc.2013.00328. eCollection 2014 Jan 13.

44.

Circulating inflammation markers and prospective risk for lung cancer.

Shiels MS, Pfeiffer RM, Hildesheim A, Engels EA, Kemp TJ, Park JH, Katki HA, Koshiol J, Shelton G, Caporaso NE, Pinto LA, Chaturvedi AK.

J Natl Cancer Inst. 2013 Dec 18;105(24):1871-80. doi: 10.1093/jnci/djt309. Epub 2013 Nov 18.

45.

Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial.

Bhutani M, Turkbey B, Tan E, Kemp TJ, Pinto LA, Berg AR, Korde N, Minter AR, Weiss BM, Mena E, Lindenberg L, Aras O, Purdue MP, Hofmann JN, Steinberg SM, Calvo KR, Choyke PL, Maric I, Kurdziel K, Landgren O.

Leukemia. 2014 Feb;28(2):413-6. doi: 10.1038/leu.2013.268. Epub 2013 Sep 18. No abstract available.

PMID:
24045500
46.

A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma.

Purdue MP, Hofmann JN, Kemp TJ, Chaturvedi AK, Lan Q, Park JH, Pfeiffer RM, Hildesheim A, Pinto LA, Rothman N.

Blood. 2013 Aug 8;122(6):951-7. doi: 10.1182/blood-2013-01-481077. Epub 2013 Jun 27. Erratum in: Blood. 2014 May 1;123(18):2901.

47.

Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer.

Bodelon C, Polley MY, Kemp TJ, Pesatori AC, McShane LM, Caporaso NE, Hildesheim A, Pinto LA, Landi MT.

Ann Oncol. 2013 Aug;24(8):2073-9. doi: 10.1093/annonc/mdt175. Epub 2013 May 16.

48.

Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses: results from the Costa Rica Vaccine Trial.

Safaeian M, Kemp TJ, Pan DY, Porras C, Rodriguez AC, Schiffman M, Cortes B, Katki H, Wacholder S, Schiller JT, Gonzalez P, Penrose K, Lowy DR, Quint W, van Doorn LJ, Herrero R, Hildesheim A, Pinto LA.

Hum Vaccin Immunother. 2013 Jul;9(7):1399-406. doi: 10.4161/hv.24340. Epub 2013 Apr 9.

49.

HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.

Lin SW, Ghosh A, Porras C, Markt SC, Rodriguez AC, Schiffman M, Wacholder S, Kemp TJ, Pinto LA, Gonzalez P, Wentzensen N, Esser MT, Matys K, Meuree A, Quint W, van Doorn LJ, Herrero R, Hildesheim A, Safaeian M; Costa Rican Vaccine Trial Group.

PLoS One. 2013;8(1):e53067. doi: 10.1371/journal.pone.0053067. Epub 2013 Jan 2.

50.

Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®).

Kemp TJ, Safaeian M, Hildesheim A, Pan Y, Penrose KJ, Porras C, Schiller JT, Lowy DR, Herrero R, Pinto LA.

Vaccine. 2012 Dec 17;31(1):165-70. doi: 10.1016/j.vaccine.2012.10.067. Epub 2012 Oct 31.

Supplemental Content

Support Center